333 related articles for article (PubMed ID: 8590203)
1. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
Hafner E; Schuchter K; Philipp K
Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
[TBL] [Abstract][Full Text] [Related]
2. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
3. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
[TBL] [Abstract][Full Text] [Related]
5. Increased nuchal translucency as a marker for fetal chromosomal defects.
Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
[TBL] [Abstract][Full Text] [Related]
6. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
7. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
[TBL] [Abstract][Full Text] [Related]
8. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
9. First-trimester fetal nuchal translucency thickness and risk for trisomies.
Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
[TBL] [Abstract][Full Text] [Related]
10. [Screening for Down's syndrome at week 10-14 by measuring fetal nuchal translucency thickness].
Maymon R; Dreazen E; Weinraub Z; Bukovsky I; Herman A
Harefuah; 1999 Nov; 137(9):353-7, 432. PubMed ID: 11419032
[TBL] [Abstract][Full Text] [Related]
11. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population.
Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y
Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427
[TBL] [Abstract][Full Text] [Related]
12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
13. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
BJOG; 2003 Jun; 110(6):584-8. PubMed ID: 12798476
[TBL] [Abstract][Full Text] [Related]
14. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of fetal nuchal translucency.
Jackson M; Rose NC
Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243
[TBL] [Abstract][Full Text] [Related]
16. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
[TBL] [Abstract][Full Text] [Related]
17. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.
Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K
BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745
[TBL] [Abstract][Full Text] [Related]
18. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
[TBL] [Abstract][Full Text] [Related]
20. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units.
Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
